Sarah Gulliford

Learn More
Disconnected cancer research data management and lack of information exchange about planned and ongoing research are complicating the utilisation of internationally collected medical information for improving cancer patient care. Rapidly collecting/pooling data can accelerate translational research in radiation therapy and oncology. The exchange of study(More)
PURPOSE Radical radiotherapy for head and neck cancer (HNC) may deliver significant doses to brain structures. There is evidence that this may cause a decline in neurocognitive function (NCF). Radiation dose to the medial temporal lobes, and particularly to the hippocampi, seems to be critical in determining NCF outcomes. We evaluated the feasibility of two(More)
Nearly 50% of cancer patients undergo radiotherapy. Late radiotherapy toxicity affects quality-of-life in long-term cancer survivors and risk of side-effects in a minority limits doses prescribed to the majority of patients. Development of a test predicting risk of toxicity could benefit many cancer patients. We aimed to meta-analyze individual level data(More)
The incidence of late-toxicities after radiotherapy can be modelled based on the dose delivered to the organ under consideration. Most predictive models reduce the dose distribution to a set of dose-volume parameters and do not take the spatial distribution of the dose into account. The aim of this study was to develop a classifier predicting(More)
The Project Grants Scheme is NHMRC's main avenue of support for individuals and small teams of researchers undertaking biomedical, public health and health services research in Australian universities, medical schools, hospitals and other research institutions. The primary objective of the Project Grants scheme is to support individual researchers and(More)
BACKGROUND Radical chemo-radiotherapy (CRT) is an effective organ-sparing treatment option for patients with locally advanced head and neck cancer (LAHNC). Despite advances in treatment for LAHNC, a significant minority of these patients continue to fail to achieve complete response with standard CRT. By constructing a multi-modality functional imaging (FI)(More)
There is currently no standard method for delineating the oral mucosa and most attempts are oversimplified. A new method to obtain anatomically accurate contours of the oral mucosa surfaces was developed and applied to 11 patients. This is expected to represent an opportunity for improved toxicity modelling of oral mucositis.
! Abstract—In radiotherapy for head and neck cancer, the radiation dose delivered to the pharyngeal mucosa (mucosal lining of the throat) is thought to be a major contributing factor to dysphagia (swallowing dysfunction), the most commonly reported severe toxicity. There is a variation in the severity of dys-phagia experienced by patients. Understanding the(More)
A reduction in salivary flow and xerostomia are common side-effects after radiotherapy of head and neck tumours. Xerostomia can be modeled based on the dose to the parotid glands. To date, all spatial information has been discarded and dose-response models are usually reduced to the mean dose. We present novel morphological dose-response models and use(More)
Radiotherapy treatments of cancer patients are planned using dose-volume constraints. These constraints limit the volume of organs receiving a given threshold dose. We propose a new framework to predict radiation-induced toxicities and evaluate dosimetric constraints using Bayesian logistic regression with high-order interactions. The predictive power of 2(More)
  • 1